siRNA treatment reduces triglycerides in individuals with rare problem

.ANALYSIS EMPHASIZE.19 September 2024.

Plozasiran lessened triglyceride levels through 80% as well as decreased the risk of pancreatitis in patients along with persistent chylomicronemia, along with or even without a genetic medical diagnosis.